Clinical Trial

Linezolid for Syphilis Pilot Study

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The study aims to evaluate the efficacy of linezolid for the treatment of syphilis.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-09-16; most recent amendment 2026-03-09.
Status change: Recruiting → Active, Not Recruiting 2026-03-09
Status change: Not Yet Recruiting → Recruiting 2023-10-23
Trial Details
NCT Number NCT05548426
Lead Sponsor University of Southern California
Conditions Syphilis
Enrollment 24 participants
Start Date 2023-09-28
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-03-12